RAISE Act

I 116TH CONGRESS 2D SESSION H. R. 8177 To amend title XVIII of the Social Security Act to remove from the list of drugs excluded from coverage under the Medicare prescription drug program prescription oral vitamins and mineral products indicated for the treatment of iron deficiency anemia in individuals with chronic kidney disease. IN THE HOUSE OF REPRESENTATIVES SEPTEMBER 4, 2020 Mr. O’HALLERAN (for himself, Mr. BUCSHON, Mr. BUTTERFIELD, and Mr. MULLIN) introduced the following bill; which was referred to the Com- mittee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned A BILL To amend title XVIII of the Social Security Act to remove from the list of drugs excluded from coverage under the Medicare prescription drug program prescription oral vitamins and mineral products indicated for the treat- ment of iron deficiency anemia in individuals with chron- ic kidney disease. Be it enacted by the Senate and House of Representa- 1 tives of the United States of America in Congress assembled, 2 VerDate Sep 11 2014 23:50 Sep 05, 2020 Jkt 099200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6201 E:\BILLS\H8177.IH H8177 pbinns on DSKJLVW7X2PROD with BILLS 2 •HR 8177 IH SECTION 1. SHORT TITLE. 1 This Act may be cited as the ‘‘Renal Anemia Innova- 2 tion Support and Expansion Act’’ or the ‘‘RAISE Act’’. 3 SEC. 2. REMOVING CERTAIN PRESCRIPTION VITAMINS AND 4 MINERAL PRODUCTS FROM THE LIST OF 5 DRUGS EXCLUDED FROM COVERAGE UNDER 6 THE MEDICARE PRESCRIPTION DRUG PRO- 7 GRAM. 8 Section 1860D–2(e)(2)(A) of the Social Security Act 9 (42 U.S.C. 1395w–102(e)(2)(A)) is amended by inserting 10 ‘‘other than subparagraph (F) of such section (relating to 11 prescription vitamin and mineral products, except prenatal 12 vitamins and fluoride preparations) if the prescription vi- 13 tamin or mineral product is orally administered and is in- 14 dicated for treatment of iron deficiency anemia in individ- 15 uals with chronic kidney disease,’’ after ‘‘other than sub- 16 paragraph (E) of such section (relating to smoking ces- 17 sation agents),’’. 18 Æ VerDate Sep 11 2014 23:50 Sep 05, 2020 Jkt 099200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6301 E:\BILLS\H8177.IH H8177 pbinns on DSKJLVW7X2PROD with BILLS